Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027);Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population

Atherosclerosis

Volumn 246, Issue , 2016, Pages 141-147

  Ueshima, Hirotsugu ^a   Kadowaki, Takashi ^a   Hisamatsu, Takashi ^a   Fujiyoshi, Akira ^a   Miura, Katsuyuki ^a   Ohkubo, Takayoshi ^b   Sekikawa, Akira ^c   Kadota, Aya ^a   Kadowaki, Sayaka ^a   Nakamura, Yasuyuki ^d   Miyagawa, Naoko ^a   Okamura, Tomonori ^e   Kita, Yoshikuni ^f   Takashima, Naoyuki ^a   Kashiwagi, Atsunori ^g   Maegawa, Hiroshi ^a   Horie, Minoru ^a   Yamamoto, Takashi ^a   Kimura, Takeshi ^h   Kita, Toru ⁱ  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d RYUKOKU UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f TSURUGA NURSING UNIVERSITY   (Japan)

^g Kusatsu General Hospital   (Japan)

^h KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ Kobe Home Care Institute General Incorporated Foundation   (Japan)

Author keywords

Carotid intima media thickness; Carotid plaque; Coronary artery calcification; Lp PLA2; Mendelian randomization

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; PLA2G7 PROTEIN, HUMAN;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; ASYMPTOMATIC DISEASE; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY DISEASES; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; JAPAN; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; VASCULAR CALCIFICATION;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; AGED; ASYMPTOMATIC DISEASES; BIOMARKERS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; JAPAN; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; VASCULAR CALCIFICATION;

EID: 84954304737     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2018.07.039     Document Type: Erratum

References (29)

1. Rosenson R.S. Lp-PLA(2) and risk of atherosclerotic vascular disease. Lancet 2010, 375:1498-1500.
2. Garza C.A., Montori V.M., McConnell J.P., et al. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin. Proc. 2007, 82:159-165.
3. Wilensky R.L., Macphee C.H. Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr. Opin. Lipidol. 2009, 20:415-420.
4. Yamada Y., Yoshida H., Ichihara S., et al. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. Atherosclerosis 2000, 150:209-216.
5. Jang Y., Kim O.Y., Koh S.J., et al. The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men. J. Clin. Endocrinol. Metab. 2006, 91:3521-3527.
6. Hou L., Chen S., Yu H., et al. Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study. Hum. Genet. 2009, 125:11-20.
7. Kruse S., Mao X.Q., Heinzmann A., et al. The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Am. J. Hum. Genet. 2000, 66:1522-1530.
8. Hiramoto M., Yoshida H., Imaizumi T., et al. A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke. Stroke 1997, 28:2417-2420.
9. Stafforini D.M., Satoh K., Atkinson D.L., et al. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 1996, 97:2784-2791.
10. Smith G.D., Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int. J. Epidemiol. 2003, 32:1-22.
11. Lp-PLA2 Studies Collaboration, Thompson A., Gao P., et al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 2010, 375:1536-1544.
12. Mora S., Otvos J.D., Rifai N., et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009, 119:931-939.
13. Hoogeveen R.C., Gaubatz J.W., Sun W., et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1069-1077.
14. Kadota A., Miura K., Okamura T., et al. Carotid intima-media thickness and plaque in apparently healthy Japanese individuals with an estimated 10-year absolute risk of CAD death according to the Japan Atherosclerosis Society (JAS) guidelines 2012: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). J. Atheroscler. Thromb. 2013, 20:755-766.
15. Hisamatsu T., Fujiyoshi A., Miura K., et al. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population. Atherosclerosis 2014, 236:237-243.
16. Zaid M., Fujiyoshi A., Miura K., et al. High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men. Atherosclerosis 2015, 239:444-450.
17. Sekikawa A., Curb J.D., Ueshima H., et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J. Am. Coll. Cardiol. 2008, 52:417-424.
18. Sekikawa A., Ueshima H., Kadowaki T., et al. Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am. J. Epidemiol. 2007, 165:617-624.
19. Sutton-Tyrrell K., Wolfson S.K., Thompson T., et al. Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke 1992, 23:215-220.
20. Sutton-Tyrrell K., Lassila H.C., Meilahn E., et al. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998, 29:1116-1121.
21. Fujiyoshi A., Miura K., Ohkubo T., et al. Cross-sectional comparison of coronary artery calcium scores between Caucasian men in the United States and Japanese men in Japan: the multi-ethnic study of atherosclerosis and the Shiga epidemiological study of subclinical atherosclerosis. Am. J. Epidemiol. 2014, 180:590-598.
22. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 1990, 15:827-832.
23. Sekikawa A., Curb J.D., Edmundowicz D., et al. Coronary artery calcification by computed tomography in epidemiologic research and cardiovascular disease prevention. J. Epidemiol. 2012, 22:188-198.
24. Mao S.S., Pal R.S., McKay C.R., et al. Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner. J. Comput. Assist. Tomogr. 2009, 33:175-178.
25. Nakamura M., Sato S., Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J. Atheroscler. Thromb. 2003, 10:145-153.
26. Otvos J.D., Jeyarajah E.J., Cromwell W.C. Measurement issues related to lipoprotein heterogeneity. Am. J. Cardiol. 2002, 90:22i-29i.
27. The Emerging Risk Factors Collaboration Lipid-related Markers and cardiovascular disease prediction. JAMA 2012, 307:2499-2506.
28. Stability Investigators, White H.D., Held C., et al. Darapladib for preventing ischemic events in stable coronary heart disease. N. Engl. J. Med. 2014, 370:1702-1711.
29. O'Donoghue M.L., Braunwald E., White H.D., et al. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA 2014, 312:1006-1015.